Anthem Biosciences Statistics

Total Valuation

BOM:544449 has a market cap or net worth of INR 367.55 billion. The enterprise value is 358.33 billion.

Market Cap	367.55B
Enterprise Value	358.33B

Important Dates

The last earnings date was Saturday, November 8, 2025.

Earnings Date	Nov 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	561.61M
Shares Outstanding	n/a
Shares Change (YoY)	-1.04%
Shares Change (QoQ)	+1.00%
Owned by Insiders (%)	80.41%
Owned by Institutions (%)	6.84%
Float	61.92M

Valuation Ratios

The trailing PE ratio is 71.21 and the forward PE ratio is 61.01.

PE Ratio	71.21
Forward PE	61.01
PS Ratio	17.70
PB Ratio	13.35
P/TBV Ratio	13.37
P/FCF Ratio	119.08
P/OCF Ratio	58.01
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 46.45, with an EV/FCF ratio of 116.09.

EV / Earnings	69.42
EV / Sales	17.25
EV / EBITDA	46.45
EV / EBIT	54.29
EV / FCF	116.09

Financial Position

The company has a current ratio of 4.71, with a Debt / Equity ratio of 0.04.

Current Ratio	4.71
Quick Ratio	3.47
Debt / Equity	0.04
Debt / EBITDA	0.14
Debt / FCF	0.36
Interest Coverage	89.17

Financial Efficiency

Return on equity (ROE) is 20.83% and return on invested capital (ROIC) is 15.85%.

Return on Equity (ROE)	20.83%
Return on Assets (ROA)	13.80%
Return on Invested Capital (ROIC)	15.85%
Return on Capital Employed (ROCE)	23.40%
Revenue Per Employee	10.58M
Profits Per Employee	2.63M
Employee Count	1,825
Asset Turnover	0.70
Inventory Turnover	3.28

Taxes

In the past 12 months, BOM:544449 has paid 2.39 billion in taxes.

Income Tax	2.39B
Effective Tax Rate	31.65%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	713.38
200-Day Moving Average	n/a
Relative Strength Index (RSI)	41.91
Average Volume (20 Days)	194,252

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:544449 had revenue of INR 20.77 billion and earned 5.16 billion in profits. Earnings per share was 9.21.

Revenue	20.77B
Gross Profit	11.76B
Operating Income	6.60B
Pretax Income	7.55B
Net Income	5.16B
EBITDA	7.70B
EBIT	6.60B
Earnings Per Share (EPS)	9.21

Full Income Statement

Balance Sheet

The company has 10.32 billion in cash and 1.10 billion in debt, giving a net cash position of 9.22 billion.

Cash & Cash Equivalents	10.32B
Total Debt	1.10B
Net Cash	9.22B
Net Cash Per Share	n/a
Equity (Book Value)	27.53B
Book Value Per Share	49.04
Working Capital	17.20B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.34 billion and capital expenditures -3.25 billion, giving a free cash flow of 3.09 billion.

Operating Cash Flow	6.34B
Capital Expenditures	-3.25B
Free Cash Flow	3.09B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 56.61%, with operating and profit margins of 31.78% and 24.85%.

Gross Margin	56.61%
Operating Margin	31.78%
Pretax Margin	36.36%
Profit Margin	24.85%
EBITDA Margin	37.07%
EBIT Margin	31.78%
FCF Margin	14.86%

Dividends & Yields

BOM:544449 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.04%
Shareholder Yield	1.04%
Earnings Yield	1.40%
FCF Yield	0.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6